1. In Vivo

Rezo’s Platform Could ‘Fundamentally Shift’ Drug Discovery

 
• By Lucie Ellis-Taitt

Rezo’s chief technology officer Sourav Bandyopadhyay discusses the company's focus on leveraging AI and machine learning to accelerate drug discovery and its potential for partnerships with big pharma.  

Innovation concept presented by a consultant in management on webinar screen

Rising Leaders Home

Sourav Bandyopadhyay was a tenured professor at University of California, San Francisco and associate director of the cancer center when he left those roles to

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from New Science

More from In Vivo